Drug Type Small molecule drug |
Synonyms Sodium Chloride/Potassium Chloride/Sodium Sulfate/PEG 4000, Sodium Chloride/Potassium Chloride/Sodium Sulfate/Polyethylene Glycol 4000, 塩化ナトリウム/塩化カリウム/無水硫酸ナトリウム/ポリエチレングリコール4000 + [3] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Dec 2012), |
Regulation- |
Molecular FormulaClNa |
InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M |
CAS Registry7647-14-5 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Intestinal Diseases | Japan | 25 Dec 2012 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 2 | Japan | - | 15 Aug 2014 |
| Colonic Cancer | Phase 2 | Germany | 01 Oct 2012 | |
| Gastroparesis | Phase 1 | United Kingdom | 01 Sep 2006 |
Not Applicable | - | 32 | (Low Volume Prep (Prepopik)) | ajbqohibtw(tiksiayxpg) = yodvdqhihc anbfihmuaq (mitowzdrbq, 1.62) View more | - | 17 Jul 2020 | |
(Moderate Volume Prep (Moviprep)) | ajbqohibtw(tiksiayxpg) = tzcybtbrlg anbfihmuaq (mitowzdrbq, 1.55) View more | ||||||
Phase 3 | - | 140 | (MOVIPREP (Morning-only Dose)) | wrpoyfglyd = ssprvwaajg lmznxradwk (ijlnxdpxcm, ljbrnoblyx - kajhhmlnpk) View more | - | 15 May 2014 | |
(MOVIPREP (Split-dose)) | wrpoyfglyd = jmtxmvjczn lmznxradwk (ijlnxdpxcm, hmcxyjigdi - zuzlruvfzz) View more |





